Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (7), 3040-3052

Avapritinib: A Selective Inhibitor of KIT and PDGFRα That Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines

Affiliations

Avapritinib: A Selective Inhibitor of KIT and PDGFRα That Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines

Chung-Pu Wu et al. Mol Pharm.

Abstract

The frequent occurrence of multidrug resistance (MDR) conferred by the overexpression of ATP-binding cassette (ABC) transporters ABCB1 and ABCG2 in cancer cells remains a therapeutic obstacle for scientists and clinicians. Consequently, developing or identifying modulators of ABCB1 and ABCG2 that are suitable for clinical practice is of great importance. Therefore, we have explored the drug repositioning approach to identify candidate modulators of ABCB1 and ABCG2 from tyrosine kinase inhibitors with known pharmacological properties and anticancer activities. In this study, we discovered that avapritinib (BLU-285), a potent, selective, and orally bioavailable tyrosine kinase inhibitor against mutant forms of KIT and platelet-derived growth factor receptor alpha (PDGFRA), attenuates the transport function of both ABCB1 and ABCG2. Moreover, avapritinib restores the chemosensitivity of ABCB1- and ABCG2-overexpressing MDR cancer cells at nontoxic concentrations. These findings were further supported by results of apoptosis induction assays, ATP hydrolysis assays, and docking of avapritinib in the drug-binding pockets of ABCB1 and ABCG2. Altogether, our study highlights an additional action of avapritinib on ABC drug transporters, and a combination of avapritinib with conventional chemotherapy should be further investigated in patients with MDR tumors.

Keywords: P-glycoprotein; breast cancer resistance protein; chemoresistance; combination chemotherapy with BLU-285; modulators.

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no competing financial interest.

Similar articles

See all similar articles

Publication types

LinkOut - more resources

Feedback